3′-Azido-3′-deoxythymidine (AZT) inhibits thymidine phosphorylation in isolated rat liver mitochondria: A possible mechanism of AZT hepatotoxicity
Authors:
- Alice T. BentleyABAlice T. Bentley
- Edward E. McKeeEMEdward E. McKee
- 1 April 2006
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 71 (9) , 1342-1348
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Adverse Effects of Antiretroviral Therapy in HIV-1 Infected ChildrenJournal of Tropical Pediatrics, 2005
- Dilated Cardiomyopathy in an Adult Human Immunodeficiency Virus Type 1-Positive Patient Treated with a Zidovudine-Containing Antiretroviral RegimeClinical Infectious Diseases, 2003
- Zidovudine Phosphorylation and Mitochondrial Toxicity in VitroToxicology and Applied Pharmacology, 2001
- Differential Incorporation and Removal of Antiviral Deoxynucleotides by Human DNA Polymerase γJournal of Biological Chemistry, 2001
- Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving ZidovudineClinical Infectious Diseases, 1995
- Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.Journal of Clinical Investigation, 1992
- Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunctionAnnals of Neurology, 1991
- Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathyThe Lancet, 1991
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Regulation of thymidine kinase activity in the cell cycle by a labile proteinJournal of Cellular Physiology, 1985